recent
Gilgamesh Receives $14 Million NIDA Grant to Develop Ibogaine Analog for Addiction Treatment
Fluence Webinar to Explore Principles of Psychotherapeutic Touch in Psychedelic Therapy
After ‘Positive’ FDA Meeting, Cybin Looks Ahead to Phase 3 CYB003 Program
